Copyright
©The Author(s) 2023.
World J Gastroenterol. Sep 7, 2023; 29(33): 4927-4941
Published online Sep 7, 2023. doi: 10.3748/wjg.v29.i33.4927
Published online Sep 7, 2023. doi: 10.3748/wjg.v29.i33.4927
miRNAs | Change | Targets | Effect on HIRI | Models | Ref. |
miR-34a | Up | Nrf-2, SIRT1 | Overexpression aggravates, downregulation alleviates | Rats, mice and RAW264.7 | [66,68-71] |
miR-34a-5p | Up | NF-κB /JNK/ P38 | Overexpression alleviates | Human, rats, 7702 cells, AML12 cells | [72] |
miR-122 | Up | Nrf2, PHD1 | Overexpression aggravates, overexpression alleviates | Rats, mice and human | [69-71,78] |
miR-370 | Up | TbRII, NF-κB, Blc2/BAX | Downregulation alleviates | Mice and AML12 | [79,80,83] |
miR-17 | Up | Stat3 | Overexpression aggravates | Mice and AML12 | [96] |
miRNA-155 | Up | CD80, CD86, MHC-II | Knock out alleviates | Mice, Kupffer cells, AML12 cells, primary hepatocytes | [97] |
MiR-223 | Up | Biomarker | Mice and human | [98] | |
miR-494 | Up | HIF-1α/HO-1, PI3K/Akt pathway | Overexpression alleviates | Mice, L02 cells, rats | [65,84,85] |
miR-27a-5p | Up | Bach1 | Overexpression alleviates, downregulation aggravates | Mice and AML12 cells | [99] |
miRNA-191 | Up | ZONAB/Cyclin D1 | Overexpression aggravates, knock out alleviates | Mice and LO2 cells | [100] |
miR-450b-5p | Up | CRYAB/NF-κB, Akt1/mTOR | Downregulation alleviates | Mice and RAW 264.7 cells | [101] |
miR-218-5p | Up | GAB2/PI3K/AKT | downregulation alleviates, overexpression aggravates | mice | [102] |
miR-494 | Down | PTEN/PI3K/AKT | Overexpression alleviates | Rats and AML12 cells | [86] |
miR-146b | Down | TRAF6, NF-κB | Downregulation aggravates | Rats | [103] |
miR-330-3p | Down | PGAM5 | Overexpression alleviates, downregulation aggravates | Mice and AML12 cells | [104] |
miR-1246 | Down | IL-6-gp130-STAT3 | Downregulation aggravates | Mice and hUCB-MSCs | [105] |
miR-142 | Down | HMGB1/TLR4/NF-κB | Overexpression alleviates, downregulation aggravates | Mice and NCTC 1469 cells | [93] |
miR-96 | Down | FOXO4 | Overexpression alleviates, downregulation aggravates | Mice and primary hepatocytes | [92] |
miR-494 | Down | PTEN/PI3K/AKT | Overexpression alleviates | L02 cells; rats, AML12 cells | [84,86] |
miR-30b | Down | Atg12-Atg5 | Downregulation aggravates | Mice and AML12 | [106] |
miR-146a | Down | IRAK1, TRAF6 | Overexpression alleviates | Mice and RAW264.7 | [107] |
miR-124 | Down | Rab38, AKT pathway | Overexpression alleviates | Rats and L02 cells | [108] |
miR-20b-5p | Down | SIRT1 | Overexpression alleviates | Rats | [67] |
miRNA-182-5p | No detect | TLR4 | Overexpression alleviates | Mice and RAW264.7 | [109] |
miR-192-5p | Up/Down | Zeb2 | Downregulation alleviates | Mice and Hepa1-6 cells, human | [90] |
125b-5p | Down | Myd88, c-Fos and A20 | No functional tests | Mice | [87] |
miR-501-3p | Down | Myd88, c-Fos and A20 | No functional tests | Mice | [87] |
miR-133a-5p | Down | MAPK6 | Overexpression alleviates, downregulation aggravates | Rats and QSG-7701 | [95] |
miR-214 | Down | TRAF1/ASK1/JNK | Overexpression alleviates | Mice and AML12 cells | [110] |
miR-449b-5p | Down | HMGB1, NF-κB | Overexpression alleviates | Rats and L02 cells | [111] |
miR-142-3p | Down | MARCKS | Overexpression alleviates, downregulation aggravates | Mice and AML12, HepG2 cells | [112] |
miR-24-3p | Down | STING | Overexpression alleviates | Mice | [113] |
miR-9-5p | Down | CXCR4 | Overexpression alleviates | Liver sinusoidal endothelial cells | [114] |
miR-141-3p | Down | Keap1/Nrf2 | Overexpression alleviates, downregulation aggravates | Human, mice and LO2 cells | [89] |
miR-194 | Down | PHLDA1 | Overexpression alleviates | Mice and RAW 264.7 cells | [115] |
miR-9-3p | Down | FNDC3VB | Overexpression alleviates, downregulation aggravates | Rats | [94] |
miR-29a-3p | No change | Ireb2 | Overexpression alleviates, downregulation aggravates | Rats and BMMSC | [116] |
miR-124-3p | Down | TRAF3/CREB, Steap3 | Overexpression alleviates, downregulation aggravates | Mice and Normal BNL Rats, CL.2 hepatocytes, BMMSC | [117,118] |
miR-140-5p | Down | CAPN1 | Overexpression alleviates, downregulation aggravates | Mice and AML12 cells | [119] |
Mechanisms | miRNAs | Ref. |
Apoptosis | miR-1, miR-17, miR-133, miR-205, miR-34a, miR-124, miR-146a, miR-494, miR-192-5p, miR-133a-5p, miRNA-155, miR-146b, miR-27a-5p, miR-214, miRNA-191, miR-370, miR-449b-5p, miRNA-142-3p, miRNA-24-3p, miR-9-5p, miR-96, miRNA-141-3p, miR-9-3p, miR-218-5p, miR-124-3p, miR-34a-5p, miR-142, miR-140-5p | [68,72,83,84,86,89-95,97,99,100,102,107,108,110-113,114,117,119] |
Inflammatory responses | miRNA-182-5p, miR-370, miR-34a, miR-146a, 125b-5p and miR-501-3p, miRNA-155, miR-146b, miR-148a, miR-1246, MiRNA-142-3p, miRNA-24-3p, miR-9-5p, miR-194, miR-9-3p, miR-124-3p, miR-218-5p, miR-450b-5p, miR-142, miR-140-5p | [68,79,80,87,93,94,97,101-103,105,107,109,112-115,117,119,120] |
Oxidative stress | miR-34a, miR-122, miR-494, miR-9-3p, miR-218-5p, miR-142 | [69,70,71,86,93,94,102] |
Autophagy | miR-17, miR-30b, miR-330-3p | [96,104,106] |
Ferroptosis | miR-29a-3p, miR-124-3p | [116,118] |
lncRNAs | Change | Targets | Effect on HIRI | Models | Ref. |
TUG1 | Up | Brg1, miR-194/SIRT1 | Alleviate | Mice, AML12 cells, WRL-68 cells | [133,144] |
SNHG1 | Up | miR-186-5p/YY1 | Alleviate | AML12 cells | [145] |
NEAT1 | Up | - | Aggravate | HL7702 cells | [134] |
Gm4419 | Up | miR-455/SOX6 axis | Aggravate | Rats and BRL-3A | [138] |
AK139328 | Up | Akt signaling pathway and NF-κB | Aggravate | Mice and primary mouse hepatocyte | [130] |
AK054386 | Up | miR-199 | Aggravate | Mice and BNL-CL2 cells | [140] |
HOTAIR | Up | miR-20b-5p/ATG7 | Aggravate | Mice and primary mouse hepatocyte | [141] |
MALAT1 | Up | HMGB1-TLR4 | Aggravate | HL7702 cells | [135] |
Hnf4αos | Up | Hnf4α/miR-23a | Aggravate | Human, mice, primary mouse hepatocyte and L02 cells | [136] |
KCNQ1OT1 | Up | miR-142a-3p/HMGB1 | Aggravate | Mice and primary mouse hepatocyte | [15] |
CCAT1 | Down | caspase-3, cyclin D1 | Aggravate | HL7702 cells | [139] |
MEG3 | Down | miR-34a/Nrf2 | Aggravate | Mice and HL7702 cells | [137] |
- Citation: Shao JL, Wang LJ, Xiao J, Yang JF. Non-coding RNAs: The potential biomarker or therapeutic target in hepatic ischemia-reperfusion injury. World J Gastroenterol 2023; 29(33): 4927-4941
- URL: https://www.wjgnet.com/1007-9327/full/v29/i33/4927.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i33.4927